Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience

BACKGROUND: No study has evaluated the direct annual costs of inflammatory bowel disease patients treated with anti-tumour necrosis factor therapy. OBJECTIVES: The purpose of this study was to identify annual direct costs and main cost drivers of anti-tumour necrosis factor-treated inflammatory bowe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:United European Gastroenterol J
Hauptverfasser: Lawton, Jean, Achit, Hamza, Pouillon, Lieven, Boschetti, Emmanuelle, Demore, Béatrice, Matton, Thierry, Tournier, Charlène, Prodel, Martin, Peyrin-Biroulet, Laurent, Guillemin, Francis
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2019
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6683635/
https://ncbi.nlm.nih.gov/pubmed/31428415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619853448
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge